4.4 Article

METFORMIN INCREASES PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR γ CO-ACTIVATOR-1α AND UTROPHIN A EXPRESSION IN DYSTROPHIC SKELETAL MUSCLE

期刊

MUSCLE & NERVE
卷 52, 期 1, 页码 139-142

出版社

WILEY-BLACKWELL
DOI: 10.1002/mus.24692

关键词

AMPK; mdx mice; metformin; PGC-1 alpha; utrophin A

向作者/读者索取更多资源

Introduction: Metformin (MET) stimulates skeletal muscle AMP-activated protein kinase (AMPK), a key phenotype remodeling protein with emerging therapeutic relevance for Duchenne muscular dystrophy (DMD). Our aim was to identify the mechanism of impact of MET on dystrophic muscle. Methods: We investigated the effects of MET in cultured C2C12 muscle cells and mdx mouse skeletal muscle. Expression of potent phenotypic modifiers was assessed, including peroxisome proliferator-activated receptor (PPAR)gamma coactivator-1 alpha (PGC-1 alpha), PPAR delta, and receptor-interacting protein 140 (RIP140), as well as that of the dystrophin-homolog, utrophin A. Results: In C2C12 cells, MET augmented expression of PGC-1 alpha, PPAR delta, and utrophin A, whereas RIP140 content was reciprocally downregulated. MET treatment of mdx mice increased PGC-1 alpha and utrophin A and normalized RIP140 levels. Conclusions: In this study we identify the impact of MET on skeletal muscle and underscore the timeliness and importance of investigating MET and other AMPK activators as relevant therapeutics for DMD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据